These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H. Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708 [Abstract] [Full Text] [Related]
4. Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus. Carlson JA, Amin S, Malfetano J, Tien AT, Selkin B, Hou J, Goncharuk V, Wilson VL, Rohwedder A, Ambros R, Ross JS. Appl Immunohistochem Mol Morphol; 2001 Jun 15; 9(2):150-63. PubMed ID: 11396633 [Abstract] [Full Text] [Related]
7. Expression of mdm-2 and p53 protein in transitional cell carcinoma. Barbareschi M, Girlando S, Fellin G, Graffer U, Luciani L, Dalla Palma P. Urol Res; 1995 Jun 15; 22(6):349-52. PubMed ID: 7537927 [Abstract] [Full Text] [Related]
8. The predictive value of p53, MDM-2, cyclin D1 and Ki67 in the progression from low-grade dysplasia towards carcinoma of the larynx. Pignataro L, Capaccio P, Pruneri G, Carboni N, Buffa R, Neri A, Ottaviani A. J Laryngol Otol; 1998 May 15; 112(5):455-9. PubMed ID: 9747474 [Abstract] [Full Text] [Related]
9. Abnormal expression of MDM-2 in breast carcinomas. Bueso-Ramos CE, Manshouri T, Haidar MA, Yang Y, McCown P, Ordonez N, Glassman A, Sneige N, Albitar M. Breast Cancer Res Treat; 1996 May 15; 37(2):179-88. PubMed ID: 8750585 [Abstract] [Full Text] [Related]
10. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases. Emanuels AG, Koudstaal J, Burger MP, Hollema H. Br J Cancer; 1999 Apr 15; 80(1-2):38-43. PubMed ID: 10389975 [Abstract] [Full Text] [Related]
12. MDM-2 protein is expressed in different layers of normal human skin. Dazard JE, Augias D, Neel H, Mils V, Marechal V, Basset-Séguin N, Piette J. Oncogene; 1997 Mar 06; 14(9):1123-8. PubMed ID: 9070662 [Abstract] [Full Text] [Related]
18. Abnormal expression of MDM2 in prostate carcinoma. Leite KR, Franco MF, Srougi M, Nesrallah LJ, Nesrallah A, Bevilacqua RG, Darini E, Carvalho CM, Meirelles MI, Santana I, Camara-Lopes LH. Mod Pathol; 2001 May 06; 14(5):428-36. PubMed ID: 11353053 [Abstract] [Full Text] [Related]
19. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. McCann AH, Kirley A, Carney DN, Corbally N, Magee HM, Keating G, Dervan PA. Br J Cancer; 1995 May 06; 71(5):981-5. PubMed ID: 7734324 [Abstract] [Full Text] [Related]